KCTD9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.536200E-01
Normal-vs-Stage2
5.321800E-01
Normal-vs-Stage3
8.602800E-01
Normal-vs-Stage4
7.870000E-02
Stage1-vs-Stage2
5.185400E-01
Stage1-vs-Stage3
7.276000E-01
Stage1-vs-Stage4
2.696400E-01
Stage2-vs-Stage3
3.898600E-01
Stage2-vs-Stage4
6.411200E-01
Stage3-vs-Stage4
8.234300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.213400E-01
Normal-vs-AfricanAmerican
4.899400E-01
Normal-vs-Asian
7.594800E-01
Caucasian-vs-AfricanAmerican
9.337600E-01
Caucasian-vs-Asian
7.354600E-01
AfricanAmerican-vs-Asian
7.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.119800E-01
Normal-vs-Female
4.715000E-01
Male-vs-Female
1.541610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.051800E-01
Normal-vs-Age(41-60Yrs)
3.511600E-01
Normal-vs-Age(61-80Yrs)
6.632000E-01
Normal-vs-Age(81-100Yrs)
7.978000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.069980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.954600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.969200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.522360E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.334300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.365800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.282200E-01
Normal-vs-Daily Drinker
9.689200E-01
Normal-vs-Weekly Drinker
6.443800E-01
Normal-vs-Occasional Drinker
4.777800E-01
Normal-vs-Social Drinker
4.304200E-01
Non Drinker-vs-Daily Drinker
7.887800E-01
Non Drinker-vs-Weekly Drinker
4.069000E-01
Non Drinker-vs-Occasional Drinker
1.327240E-01
Non Drinker-vs-Social Drinker
1.213590E-01
Daily Drinker-vs-Weekly Drinker
2.979400E-01
Daily Drinker-vs-Occasional Drinker
1.261450E-01
Daily Drinker-vs-Social Drinker
1.010230E-01
Weekly Drinker-vs-Occasional Drinker
8.044200E-01
Weekly Drinker-vs-Social Drinker
5.113400E-01
Occasional Drinker-vs-Social Drinker
5.971800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.904300E-02
Normal-vs-Grade 2
8.475500E-03
Normal-vs-Grade 3
1.880130E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.980540E-04
Grade 1-vs-Grade 3
1.229910E-04
Grade 1-vs-Grade 4
4.904300E-02
Grade 2-vs-Grade 3
4.766200E-01
Grade 2-vs-Grade 4
8.475500E-03
Grade 3-vs-Grade 4
1.880130E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.878000E-01
Normal-vs-NonDiabetic
5.991200E-01
Diabetic-vs-NonDiabetic
5.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.349800E-01
Normal-vs-NoPancreatitis
6.549200E-01
Pancreatitis-vs-NoPancreatitis
6.211400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.635800E-01
Normal-vs-N1
5.376800E-01
N0-vs-N1
6.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.387800E-01
Normal-vs-TP53-NonMutant
9.973800E-01
TP53-Mutant-vs-TP53-NonMutant
4.862800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
